medigraphic.com
SPANISH

Revista Mexicana de Trasplantes

ISSN 2007-6800 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 2

<< Back Next >>

Rev Mex Traspl 2021; 10 (2)

Perioperative report of a series of cases in liver transplant patients in a Third-Level Hospital

Santibáñez-Velázquez M, Medina-García G, Olguín-Sánchez E, Meza-Jiménez G, Castillo-Barradas M
Full text How to cite this article 10.35366/101412

DOI

DOI: 10.35366/101412
URL: https://dx.doi.org/10.35366/101412

Language: Spanish
References: 25
Page: 58-63
PDF size: 241.86 Kb.


Key words:

Receptors, liver transplant, technique piggyback, hemorrhage, mortality.

ABSTRACT

The world's first liver transplant (LT) was performed in 1963 by the physician Thomas Earl Starzl and his team. In 1976 the first LT was performed in Mexico. The number of LT is low relative to patients who die annually from liver disease worldwide. Objective: To analyze the perioperative conditions of LT receptors and their possible association with complications. Material and methods: Case series in the intensive care unit, analyzing the preoperative conditions of LT subjects and their association with intra and postoperative outcome. Results: In 2019 11 subjects received ortho-topical LT with technique piggyback, six women (54.5%) and five men (45.5%), average age 50 years, with a history of alcohol intake at 9 (81.8%), the leading cause of cirrhosis was hepatitis virus "C" at 5 (45.5%). The CHILD-PUG B score, average of 9 and MELD 18. Platelet lymphocyte index (IP/L) < 10 × 104/μ/L, 6 (54.6%), bleeding 7 (63.8%) p = 0.121, postoperative mortality 2 (18%), p = 0.121. Conclusions: Subjects with IP/L< 10 × 104/μ/L, are more prone to trans- and postoperative bleeding.


REFERENCES

  1. Yoshida EM, Hussaini T. Liver transplantation: the past, the present and the legacy of Dr. Thomas Starzl. AME Med J. 2018; 3: 17.

  2. Kashimutt S, Kotzé A. Anaesthesia for liver transplantation. BJA Education. 2017; 17 (1): 35-40. doi: 10.1093/bjaed/mkw031.

  3. Gupte A, Shukla A. Liver transplantation -what the physician should know? JAPI. 2016; 64: 60-69.

  4. Krawczyk M. History of liver transplantation in Poland. Pol Przegl Chir. 2018; 90 (3): 60-68. doi: 10.5604/01.3001.0012.2070.

  5. Mendoza F. Trasplante hepático en México. Rev. Mex Traspl. 2018; 7 (1): 25-30.

  6. Boletín estadístico informativo, Centro Nacional de Trasplantes de México. (CENATRA). 2016; (1): 1.

  7. Martin P, Dimartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 Practice guideline by the American Association or the study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014; 59: 1144-1165. doi: 10.1002/hep.26972.

  8. Salvalaggio PR, Caicedo JC, de Albuquerque LC, Contreras A, García VD, Felga GE et al. Liver transplantation in Latin America: the state-of-the-art and future trends. Transplant Rev. 2014; 98 (3): 241-246. doi: 10.1097/TP.00000000000000000198.

  9. Ferreira R, Salvalaggio P, Rezende MB, Silva A, Della B, Lourenco CE et al. Liver transplantation: history, outcomes and perspectives. Review. Einstein (Sao Paulo). 2015; 13 (1): 149-152. doi: 10.1590/S1679-45082015RW3164.

  10. Zhu JH, Hussaini T, Erb SR, Márquez V, Yoshida EM. Medical complications of liver transplantation AME Med J. 2018; 3: 11. doi: 10.21037/amj.2018.01.03.

  11. Chascsa DM, Vargas HE. The gastroenterologist's guide to management of the post-liver transplant patient. Am J Gastroenterol. 2018; 113: 819-828. doi: 10.1038/s41395-018-0049-0.

  12. Miller CH, Quintini C, Dhawan A, Durand F, Heimbach J, Kim HL et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplant Rev. 2017; 101: 938-944. doi: 10.1097/TP.00000000000000001571.

  13. Nicolau-Raducu R, Gitman M, Ganier D, Loss GE, Cohen AJ, Patel H et al. Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients. Liver Transpl. 2015; 21: 13-21. doi: 10.1002/lt.23997.

  14. Briceño J, Ciria R, de la Mata M. Donor-recipient matching: myths and realities. J Hepatol. 2013; 58: 811-820. doi: 10.1016/j.jhep.2012.10.020.

  15. Chavez V, Orizaga de la C, Mejia R, Gutierrez C, Lagunas R, Viveros S. Inflammation in hemodialysis and their correlation with neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Nefro. 2017; 37:461-562. doi: org/10.1016/.nefroe.2017.03.001.

  16. Taymez DG, Ucar E, Turkmen K, Ucar R, Afsar B, Gaipov A et al. The predictive value of platelet/lymphocyte ratio in hemodialysis patients with erythropoietin resistance. Ther Apher Dial. 2016; 20: 118-121. doi: org/10.1111/1744-9987.12380.

  17. Talavera OJ, Rivas RR. IV. Pertinencia de la prueba estadística. Rev Med Inst Mex Seguro Soc. 2013; 51 (1): S30-34.

  18. Valga F, Monzón T, Henríquez F, Santana A, Pérez G. Índices plaquetas-linfocito y neutrófilo linfocito como marcadores de resistencia a la eritropoyetina en pacientes en hemodiálisis crónica: estudio transversal, multicéntrico. Nefro. 2019; 9: 1-7. doi: 10.1016/j.nefro.2019.09.007

  19. EASL Clinical Practice Guidelines: Liver transplantation European Association for the Study of the Liver. J Hepatol. 2015; 30: 1-53.

  20. ASSCAT de la European Association for the Study of the Liver, EASL Clinical Practice Guidelines. J Hepatol 2016; 64:433-485.

  21. Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Gastroenterol Hepatol. 2015; 38 (10): 600-618. doi: 10.1016/j.gastrohep.2015.06.008.

  22. Global Database on Body Mass Index World Health Organization [Consulted 8 Oct 2014]. Available in: www.who.int/bmi/index.jsp?introPage=intro3.html.

  23. Saab S, Lalezari D, Pruthi P, Alper T, Tong MJ. The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int. 2015; 35 (1): 164-167. doi: 10.1111/liv.12431.

  24. Shamah-Levy T, Ruiz-Matus C, Rivera-Dommarco J, Kuri-Morales P, Cuevas-Nasu L, Jiménez-Corona ME, et al. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2017, 11-12.

  25. Brezeanu NL, Brezeanu CR, Diculesco M, Droc G. Anaesthesia for Liver Transplantation: An Update. J Crit Care Med. 2020; 6 (2): 91-100. doi: 10.2478/jccm-2020-0011.




Figure 1
Table 1
Table 2

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Traspl. 2021;10